139 citations
- University of Wisconsin–MadisonUS5 papers
- North Carolina State UniversityUS4 papers
- AbbVie (United States)US3 papers
- Merck & Co., Inc., Rahway, NJ, USA (United States)US3 papers
- Purdue University West LafayetteUS3 papers
- Sanofi (United States)US3 papers
- Bayer (Canada)CA2 papers
- CSL (United States)US2 papers
- Duke UniversityUS2 papers
- Harvard UniversityUS2 papers
- Stanford UniversityUS2 papers
- Texas A&M UniversityUS2 papers
41 papers
Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment
Jiren Sun, Tuo Wang, Yanyao Yi +3
The area under the curve (AUC) of the mean cumulative function (MCF) has recently been introduced as a novel estimand for evaluating treatment effects in recurrent event settings,…
Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data
Ilya Lipkovich, David Svensson, Bohdana Ratitch +1
In this paper we review recent advances in statistical methods for the evaluation of the heterogeneity of treatment effects (HTE), including subgroup identification and estimation…
Bayesian Record Linkage with Variables in One File
Gauri Kamat, Mingyang Shan, Roee Gutman
In many healthcare and social science applications, information about units is dispersed across multiple data files. Linking records across files is necessary to estimate the assoc…
Sensitivity Analysis for Unmeasured Confounding in Medical Product Development and Evaluation Using Real World Evidence
Yixin Fang, Pallavi Mishra-Kalyani, Xiang Zhang +8
The American Statistical Association Biopharmaceutical Section (ASA BIOP) scientific working group on real-world evidence (RWE) has been making continuous, extended efforts towards…
OpenSSF Scorecard: On the Path Toward Ecosystem-wide Automated Security Metrics
Nusrat Zahan, Parth Kanakiya, Brian Hambleton +2
The OpenSSF Scorecard project is an automated tool to monitor the security health of open-source software. This study evaluates the applicability of the Scorecard tool and compares…
Using principal stratification in analysis of clinical trials
Ilya Lipkovich, Bohdana Ratitch, Yongming Qu +3
The ICH E9(R1) addendum (2019) proposed principal stratification (PS) as one of five strategies for dealing with intercurrent events. Therefore, understanding the strengths, limita…